Dozens of Retractions Requested for Heart Stem Cell Studies

Harvard and Brigham and Women’s Hospital disavow the work by former faculty member Piero Anversa.

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

ABOVE: © ISTOCK.COM, RAZVAN25

Harvard Medical School and Brigham and Women’s Hospital announced yesterday (October 14) that following an internal investigation they recommend the retraction of 31 papers by a former faculty member, cardiac stem cell researcher Piero Anversa, as Retraction Watch and STAT report. These studies “included falsified and/or fabricated data,” the two institutions tell Retraction Watch and STAT, adding that they have “notified all relevant journals.”

This is the latest in a series of black marks on research by Anversa, who claimed, as early as 2003, to have identified adult stem cells—dubbed c-kit cells—that can regenerate cardiac muscle. Efforts by other labs to reproduce Anversa’s findings and to use the cells to heal damaged hearts have produced contradictory and sometimes mysterious results.

In 2014, Anversa and coauthors had a paper retracted from the journal Circulation after Harvard Medical School and Brigham and Women’s determined that data were “compromised,” ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

fujirebio-square-logo

Fujirebio Receives Marketing Clearance for Lumipulse® G pTau 217/ β-Amyloid 1-42 Plasma Ratio In-Vitro Diagnostic Test

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours